Antiviral combination therapies for persistent COVID-19 in immunocompromised patients

•Immunocompromised patients require combined antiviral therapies.•In vitro synergies exist for small molecule antivirals and passive immunotherapies.•Anti-spike monoclonal antibodies lost efficacy against recent Omicron variants.•Small molecule antivirals can be combined with increased efficacy.•Com...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of infectious diseases Vol. 137; pp. 55 - 59
Main Authors Focosi, Daniele, Maggi, Fabrizio, D'Abramo, Alessandra, Nicastri, Emanuele, Sullivan, David J
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.12.2023
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…